References
- Asberg M., Traskman L., Thoren P. 5-HIAA in the cerebrospinal fluid: a biochemical suicide predictor. Archives of General Psychiatry 1976; 33: 93–97
- Asberg M. Biological factors in suicide. Suicide, A. Roy. Williams and Wilkins, Baltimore 1986
- Banki C., Arato M., Papp Z., Kurcz. Biochemical markers in suicidal patients: investigations with cerebrospinal fluid amine metabolites and neuroendocrine tests. Journal of Affective Disorders 1984; 6: 341–350
- Brown G., Ebert M., Coyer P. Aggression, suicide, and serotonin. American Journal of Psychiatry 1982; 139: 741–746
- Brown G., Goodwin F., Ballenger J. Aggression in human correlates with cerebrospinal fluid amine metabolites. Psychiatry Research 1979; 1: 131–139
- Linnoila M., Virkkunen M., Scheinin M. Low cerebrospinal fluid 5-hydroxyindoleacetic acid concentration differentiates impulsive from non-impulsive violent behavior. Life Sciences 1983; 2: 2609–2614
- Traskman L., Ashberg M., Bertilsson L., Sjostrand L. Monoamine metabolites in CSF and suicidal behavior. Archives of General Psychiatry 1981; 38: 631–636
- Virkkunen M. Reactive hypoglycemic tendency among habitually violent offenders: A further study by means of the glucose tolerance test. Neuropsychobiology 1982; 8: 35–40
- Virkkunen M. Insulin secretion during the glucose tolerance test in antisocial personality. British Journal of Psychiatry 1983; 142: 598–604
- Virkkunen M. Reactive hypoglycemic tendency among arsonists. Acta Psychiatrica Scandinavica 1984; 69: 445–452
- Virkkunen M. Insulin secretion during the glucose tolerance test among habitually violent and impulsive offenders. Aggressive Behavior 1985a; 12: 303–310
- Virkkunen M. Reactive hypoglycemic tendency among habitually violent offenders. Nurrition Reviews 1986; 44: 94–103
- Virkkunen M., Nuutaila A., Goodwin F., Linnoila M. CSF monoamine metabolites in male arsonists. Archives of General Psychiutiy. 1987
- Yamamoto HI., Negai K., Nakagawa H. Lesions involving the suprachiasmatic nucleus eliminate the glucagon response to intracranial injection of 2-deoxy-D-glucose. Endocrinology 1985; 117: 468–473